Jennifer Taylor-Cousar, MD, MSCS, ATSF

Medical Director, Clinical Research Services

President-Elect, Medical Staff

Interim Associate Vice President of Diversity, Equity and Inclusion

Co-Director, Adult Cystic Fibrosis Program

CF Therapeutics Development Network Center Director

Professor (tenured), Departments of Medicine and Pediatrics

The Tuchman Family Division of Pulmonary, Critical Care and Sleep Medicine and the Pediatric Pulmonary Division

National Jewish Health

She has been site primary investigator on more than 60 clinical studies, and national/global primary investigator on 5 clinical trials. She is an elected member of the American Society for Clinical Investigation (2020). Her investigator initiated research focuses on the development and evaluation of novel therapies for the treatment of CF, and on the unique health needs of women with CF. She is also investigating the etiology and treatment of bronchiectasis in non-human primates.

She serves on numerous local and national committees including as an advisor to the Cystic Fibrosis Foundation’s (CFF) Board of Trustees, on the CFF’s Clinical Research Advisory Board, the CFF Racial Justice Working Group, the CF TDN’s Clinical Research Executive Committee and as Chair of the CF TDN’s Women’s Health Research Working Group. She is an Associate Editor for the Journal of Cystic Fibrosis. She serves on the American Thoracic Society (ATS) Scientific Grant Review and Clinical Problems Programming Committees (Chair 2020-2021). She has co-chaired numerous sessions and given invited lectures at the ATS International Conference, and the North American, European, Israeli, Mexican, Spanish and Australian CF Conferences, as well as at regional CF and pulmonary conferences and national and international veterinary conferences. She is an active member of the Colorado Chapter CF Board. 

Dr. Taylor-Cousar is a tenured professor of adult and pediatric pulmonary medicine at National Jewish Health (NJH), where she serves as the Medical Director of Clinical Research Services, President-elect of the medical staff, and is co-director of the Adult CF Program and Director of the CF Therapeutics Development Network (TDN) center.  She received her undergraduate degree in human biology from Stanford University in 1993, and completed her doctorate in medicine in 1998, combined residency in internal medicine and pediatrics in 2002, and her combined fellowship in adult and pediatric pulmonary medicine in 2006 at Duke University Medical Center. She obtained her Master of Clinical Science from the University of Colorado in 2015.